2.07
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
|
17.64%
7.9221
|
9.6193 | 11.56 | 11.34 | 6.9847 |
Interest Income/Expense |
0.00349
|
- | 0.0059 | 0.0128 | 0.00766 |
Operating Income/Loss |
17.64%
-7.9221
|
-9.6193 | -11.56 | -11.34 | -6.9847 |
Nonoperating Income/Loss |
91.10%
0.4959
|
0.2595 | 0.2301 | -0.3659 | 0.136 |
Income/Loss From Continuing Operations Before Tax |
23.67%
-7.4262
|
-9.729 | -10.48 | -12.44 | -6.5996 |
Income Tax Expense/Benefit |
261.41%
0.0074
|
-0.00458 | 0.0121 | 0.00644 | 0.00298 |
Income/Loss From Continuing Operations After Tax |
20.54%
-7.4336
|
-9.3553 | -11.35 | -11.71 | -6.8517 |
|
20.54%
-7.4336
|
-9.3553 | -11.35 | -11.71 | -6.8517 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,822%
29.89
|
1.0228 | 24.03 | 22.43 | 21.83 |
Basic Earnings Per Share |
24.24%
-0.25
|
-0.33 | -0.48 | -0.52 | -0.31 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):